Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Griffith

Showing results (331-340 of 565) with videos related to

Pageof 57
Sort By:
JNCI Cancer Spectrum|November 23, 2022
Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncologyStephanie L Graff, Ishwaria M Subbiah, Merry Jennifer Markham, et al.
Molecular Imaging and Biology|May 20, 2015
Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell ImagingNilantha Bandara, Alex Zheleznyak, Kaavya Cherukuri, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiationReshma Jagsi, Merav A Ben-David, Jean M Moran, et al.
Nature Medicine|June 15, 2021
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trialAditi R Saxena, Donal N Gorman, Ryan M Esquejo, et al.
JAMA|July 29, 2024
Midcareer Satisfaction and Likelihood of Leaving Current Position of Former Career Development AwardeesReshma Jagsi, Kent A Griffith, Kelly C Paradis, et al.
Breast Cancer Research and Treatment|September 28, 2005
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breastCelina G Kleer, Kent A Griffith, Michael S Sabel, et al.
Cancer|June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary siteBryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
The Breast Journal|June 27, 2007
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experienceMerav A Ben-David, David E Sturtz, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Reply to S.M. Sorscher and A.B. Hafeez BhattiReshma Jagsi, Kent A Griffith, Allison W Kurian, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?Jean M Moran, Merav A Ben-David, Robin B Marsh, et al.
Pageof 57

Showing results (331-340 of 565) with videos related to

Sort By:
Pageof 57
JNCI Cancer Spectrum|November 23, 2022
Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncologyStephanie L Graff, Ishwaria M Subbiah, Merry Jennifer Markham, et al.
Molecular Imaging and Biology|May 20, 2015
Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell ImagingNilantha Bandara, Alex Zheleznyak, Kaavya Cherukuri, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiationReshma Jagsi, Merav A Ben-David, Jean M Moran, et al.
Nature Medicine|June 15, 2021
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trialAditi R Saxena, Donal N Gorman, Ryan M Esquejo, et al.
JAMA|July 29, 2024
Midcareer Satisfaction and Likelihood of Leaving Current Position of Former Career Development AwardeesReshma Jagsi, Kent A Griffith, Kelly C Paradis, et al.
Breast Cancer Research and Treatment|September 28, 2005
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breastCelina G Kleer, Kent A Griffith, Michael S Sabel, et al.
Cancer|June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary siteBryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
The Breast Journal|June 27, 2007
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experienceMerav A Ben-David, David E Sturtz, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Reply to S.M. Sorscher and A.B. Hafeez BhattiReshma Jagsi, Kent A Griffith, Allison W Kurian, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?Jean M Moran, Merav A Ben-David, Robin B Marsh, et al.
Pageof 57